These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2211213)

  • 1. Effect of Fluosol-DA 20% and oxygen on response of C57BL/6 mice to whole-body irradiation.
    Waldow SM; Lustig RA; Brass-Marlow EL; Nunno MP; Holst RJ; Wallner PE
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):665-8. PubMed ID: 2211213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
    Rockwell S; Mate TP; Irvin CG; Nierenburg M
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
    Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
    Holden SA; Herman TS; Teicher BA
    Radiother Oncol; 1990 May; 18(1):59-70. PubMed ID: 2113698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in RBC flux, acidosis and oxygenation in tumour microregions by Fluosol-DA 20%.
    Lee I; Cunningham WP; Levitt SH
    Int J Radiat Biol; 1991 Oct; 60(4):695-705. PubMed ID: 1680148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
    Chaplin DJ; Horsman MR; Aoki DS
    Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
    Teicher BA; Herman TS; Holden SA; Jones SM
    J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
    Teicher BA; Holden SA; Rose CM
    Int J Cancer; 1986 Aug; 38(2):285-8. PubMed ID: 3089945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
    Teicher BA; Herman TS; Rose CM
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of complications in long-term survivors after treatment with Fluosol and oxygen as an adjuvant to radiation therapy for high-grade brain tumors.
    Evans RG; Kimler BF; Morantz RA; Batnitzky S
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):649-52. PubMed ID: 8330996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
    Morton JD; Porter E; Yabuki H; Nath R; Rockwell S
    Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
    Teicher BA; Rose CM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1311-3. PubMed ID: 3093415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
    Teicher BA; Herman TS; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):286-91. PubMed ID: 3131033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing.
    Teicher BA; Holden SA; Rose CM
    Int J Cancer; 1985 Nov; 36(5):585-9. PubMed ID: 3932225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of tumor radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen.
    Martin DF; Porter EA; Rockwell S; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1987 May; 13(5):747-51. PubMed ID: 3570898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation.
    Teicher BA; Herman TS; Hopkins RE; Menon K
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):969-74. PubMed ID: 1917627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
    Fingar VH; Mang TS; Henderson BW
    Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA; Bernal SD; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system.
    Ravis WR; Ramakanth S; Brzozowski DM; Hamrick ME
    J Pharm Pharmacol; 1992 Mar; 44(3):219-23. PubMed ID: 1354727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
    Holden SA; Teicher BA; McIntosh NL; Rose CM
    Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.